Skip to main content
. 2022 Apr 27;11(9):e025171. doi: 10.1161/JAHA.121.025171

Figure 2. Prognostic impact of ischemia with nonobstructive coronary arteries and coronary microvascular disease.

Figure 2

The cumulative incidence of major adverse cardiovascular event at 5 years were compared according to presence of (A) ischemia with nonobstructive coronary arteries and (B) coronary microvascular disease. Adjusted covariates in the multivariable model included age, sex, diabetes, hyperlipidemia, and previous percutaneous coronary intervention. CMD indicates coronary microvascular disease; HR, hazard ratio; INOCA, ischemia with nonobstructive coronary arteries; and MACE, major adverse cardiovascular event.